# Sava Technologies

> A wearable microsensor platform for continuous glucose and multi-biomarker monitoring.

## Why it is interesting

Sava pairs a shorter glucose microsensor with an established diabetes-distribution partner. Its Series B is tied directly to manufacturing scale-up, a pivotal clinical study and a planned European launch, making commercialization execution more important than another prototype milestone.

## Profile

- **Latest funding:** Series B — $36M (October 9, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $63M
- **Stage:** series-b
- **Status:** private
- **Industries:** healthtech, hardware-semiconductors
- **Coverage:** full
- **Last updated:** 2026-10-09T19:00:00.000Z
- **Latest funding investors:** Ascensia Diabetes Care, Balderton Capital, Norrsken VC, Simplyhealth Ventures, JamJar Investments, Pentland Ventures

## Key facts

- Raised a $36 million Series B led by Ascensia Diabetes Care on October 9, 2026.
- Signed a European commercialization and distribution agreement with Ascensia.
- Plans a pivotal clinical study and targets CE approval for non-adjunctive use within 18 to 24 months.

## Funding history

- Series B · $36M · October 9, 2026
  Source: https://www.sava.health/post/sava-raises-36m-series-b-and-signs-european-deal-with-ascensia-for-its-next-generation-glucose-micr
- Series A · $19M · July 31, 2025
  Source: https://www.sava.health/post/sava-raises-19m-series-a-amid-world-first-clinical-results-for-next-gen-biosensor
- Seed · $8M · 2024
  Source: https://www.sava.health/post/sava-raises-8-million-in-seed-funding-to-build-preventative-personalised-precision-health-monitoring-at-scale

## Investors in our directory

- https://venturecapitaltracker.com/fund/balderton-capital

## Related articles

- https://venturecapitaltracker.com/sava-raises-36m-series-b-ascensia-glucose-sensor-deal

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 9, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/sava-technologies